To address the skills gaps in the UK life sciences sector and explore how virtual reality (VR) can enhance training for future medicine makers, particularly in practical applications.
Key Findings:
The UK has seen a 41% decline in industry clinical trials from 2017 to 2021, indicating a critical need for skilled professionals.
The UK has fallen from 4th to 98th in global pharmaceutical trade balance since 2010, reflecting a loss of competitive edge.
52% of engineering graduates and 64% of master's students in chemical engineering are from overseas, highlighting reliance on foreign talent.
The industry forecasts a need for 145,000 new jobs in Bio/Pharma over the next decade, underscoring the urgency for effective training solutions.
Interpretation:
The decline in the UK's pharmaceutical sector highlights the urgent need for innovative training solutions like VR to bridge skills gaps and retain talent.
Limitations:
VR lacks haptic feedback, limiting the realism of hands-on training.
Dependence on technology may not suit all learning styles.
Potential issues with accessibility and the digital divide among trainees.
Conclusion:
VR presents a promising solution to address the training challenges in the life sciences sector, enabling more effective preparation of future medicine makers and potentially revitalizing the industry.
